Report Library
View More
Datamonitor Healthcare Infectious D...
June 7, 2023
Datamonitor Healthcare Infectious D...
June 7, 2023
Datamonitor Healthcare Oncology: Pa...
June 7, 2023
Datamonitor Healthcare Oncology: Tu...
June 7, 2023
Acute Myeloid Leukemia (AML) KOL In...
June 6, 2023
Acute Myeloid Leukemia (AML) KOL In...
June 6, 2023
Datamonitor Healthcare CV&Met: Isch...
June 6, 2023
Datamonitor Healthcare CNS: Hunting...
June 6, 2023
Acute Myeloid Leukemia (AML) KOL In...
June 5, 2023
Acute Myeloid Leukemia (AML) KOL In...
June 5, 2023
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 6/6/23 | BridgeBio (BBIO) | Truseltiq for Gastric Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/6/23 | AstraZeneca (AZN) | Nirsevimab for Respiratory Syncytial Virus (RSV) Prevention | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/5/23 | Akero Therapeutics (AKRO) | Efruxifermin for Non-Alcoholic Steatohepatitis (NASH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/5/23 | Innovent Biologics (1801) | Sintilimab for Nasopharyngeal Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/5/23 | Ultragenyx (RARE) | UX143 for Osteogenesis Imperfecta (OI) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/09/23 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 06/09/23 | Subscribers Only | Subscribers Only | Regulatory - FDA Advisory Panel Meeting |
| 06/09/23 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 06/09/23 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 06/09/23 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
